我院2013年抗肿瘤药物用药分析  

Analysis on antineoplastic drugs in our hospital in 2013

作　　者：陈峰恩[1] 王华[1] 

机构地区：[1]河南省新乡市第一人民医院药剂科,河南新乡453000

出　　处：《中国当代医药》2015年第3期163-164,167,共3页China Modern Medicine

摘　　要：目的分析本院2013年抗肿瘤药物用药情况,为临床合理应用抗肿瘤药物提供参考。方法对2013年本院抗肿瘤药物应用种类、金额、用药频度(DDDs)和药品限定日费用(DDC)进行统计分析。结果销售金额排名前三位的是:植物来源的抗肿瘤药及其衍生物、其他抗肿瘤药及辅助治疗药和抗肿瘤抗生素;DDDs排名前三位的是:托瑞米芬、来曲唑和阿扎司琼。结论抗肿瘤药物应用基本合理,高选择性、高效低毒性药物应用量大。Objective To analyze the medication of antineoplastic drugs in our hospital in 2013,to provide reference for clinical reasonable application. Methods The application category,money,DDDs and DDC of antineoplastic drugs in our hospital in 2013 was statistically analyzed. Results The amount of sales of the top three was plant sources of antineoplastic drugs and its derivatives,other anticancer drugs and assistant drugs and antitumor antibiotic respectively;DDDs of the top three was toremifene,letrozole and azasetron respectively. Conclusion The use of antineoplastic drugs is basically reasonable,and the application of high selectivity,high efficiency and low toxicity drug is large.

关 键 词：抗肿瘤药物 销售金额 用药频度 用药分析 

分 类 号：R969.3[医药卫生—药理学]